Oncovita is a biotech company focused on developing innovative medications and vaccines, particularly anti-cancer therapies, to save lives.
Oncovita has raised $4.9M in total funding. The most recent round was Grant. The last funding was announced in November 2023.
Oncovita's investors include France 2030.
Oncovita is headquartered in Paris, France.
Oncovita is a biotech company focused on developing innovative medications and vaccines, particularly anti-cancer therapies, to save lives.
Oncovita is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Oncovita — Funding & Investors." VCBacked, November 22, 2023, https://www.vcbacked.co/company/oncovita. Accessed August 14, 2026.
VCBacked. (2023). Oncovita — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/oncovita
{{cite web |title=Oncovita — Funding & Investors |url=https://www.vcbacked.co/company/oncovita |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated